EARLY RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PREDICTS OUTCOME AT ONE YEAR

被引:0
|
作者
Berenbaum, F. [1 ]
Pham, T. [2 ]
Fautrel, B. [3 ]
Joubert, J. M. [4 ]
De Chalus, T. [4 ]
Franca, Riou L. [5 ]
Claudepierre, P. [6 ]
机构
[1] CHU St Antoine, Paris, France
[2] CHU St Marguerite, Marseille, France
[3] CHU Pitie Salpetriere, Paris, France
[4] UCB Pharma, Colombes, France
[5] Phisquare Inst, Paris, France
[6] Grp Hosp Henri Mondor, Creteil, France
关键词
D O I
10.1016/j.jval.2013.08.1452
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A556 / A556
页数:1
相关论文
共 50 条
  • [1] EARLY RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PREDICTS OUTCOME: DATA FROM A PROSPECTIVE OBSERVATIONAL STUDY
    Saraux, A.
    Flipo, R.
    Fagnani, F.
    Massol, J.
    Combe, B.
    Huot-Marchand, P.
    Joubert, J.
    Dunkel, J.
    Cukierman, G.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A526 - A526
  • [2] EARLY RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PREDICTS OUTCOME: DATA FROM A PROSPECTIVE OBSERVATIONAL STUDY
    Saraux, A.
    Flipo, R. M.
    Fagnani, F.
    Massol, J.
    Combe, B.
    Huot-Marchand, P.
    Joubert, J. M.
    Dunkel, J.
    Cukierman, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 786 - 787
  • [3] Certolizumab Pegol In Rheumatoid Arthritis
    Duggan, Sean T.
    Keam, Susan J.
    [J]. BIODRUGS, 2009, 23 (06) : 407 - 417
  • [4] Synovial Ectopic Lymphoneogenesis Predicts Clinical Response To Certolizumab Pegol In Patients With Rheumatoid Arthritis
    Di Cicco, Maria
    Kelly, Stephen
    Humby, Frances
    Ng, Nora
    Dadoun, Sabrina
    Hands, Rebecca
    Rocher, Vidalba
    Nerviani, Alessandra
    Bombardieri, Michele
    Pitzalis, Costantino
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S556 - S556
  • [5] How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol
    Torrente-Segarra, Vicenc
    Fernandez Prada, Manuel
    Exposito Moliner, Rosa
    Garrido Punal, Noemi Patricia
    Sanchez-Andrade Fernandez, Amalia
    Lamua Riazuelo, Jose Ramon
    Olive, Alejandro
    Tovar Beltran, Juan Victor
    Ferrandez, Jose Antonio Gonzalez
    Pastor, Carmen Moragues
    Arana, Ana Urruticoechea
    Rey, Jose Rey
    Cabello, Raul Veiga
    Diez, Angel Aragon
    Fuentes, Noelia Vazquez
    Cristobal, Anna Martinez
    Alonso, Ma del Pilar Navarro
    Palau, Sergi Ordonez
    Jimenez, Alejandro Munoz
    Martin, Jose Miguel Ruiz
    Pereira, Asuncion Acosta
    Aparicio, Angel Maria Garcia
    Fernandez, Jesus Carlos
    Morcillo, Mercedes
    Serret, Emilio Giner
    Palau, Nuria Montala
    Escalera, Carlos Rodriguez
    Esteban, Jose Campos
    de Oro, Juan Jose de Agustin
    Celimendiz, Pedro Giralt
    Vilchez, Desiree Ruiz
    Gonzalez-Albo, Silvia Paredes
    Courel, Laura Garrido
    Gonzalez, Carmen Olga Sanchez
    Guzman, Maria del Pilar Ahijado
    Perez, Patricia Castro
    Portales, Rosa Garcia
    Melon, Julia Fernandez
    Orfila, Gabriel Mercadal
    Pons, Jose Raul Noguera
    Tuduri, Concepcion Moll
    Armario, Ma Dolores Garcia
    Vila, Victor Eliseo Quevedo
    Garrido, Juan Jose Lerma
    Perez, Antonio Gracia
    Aguinaga, Elena Aurrecoechea
    Cid, Amalia Rueda
    Garcia, Marina Soledad Moreno
    Cortina, Eduardo Loza
    Torrent, Delia Taverner
    [J]. RHEUMATOLOGY INTERNATIONAL, 2019, 39 (02) : 395 - 398
  • [6] How elderly rheumatoid arthritis patients respond at one year of treatment with certolizumab pegol
    Vicenç Torrente-Segarra
    Manuel Fernandez Prada
    Rosa Expósito Moliner
    Noemí Patricia Garrido Puñal
    Amalia Sánchez-Andrade Fernández
    José Ramón Lamua Riazuelo
    Alejandro Olivé
    Juan Víctor Tovar Beltrán
    [J]. Rheumatology International, 2019, 39 : 395 - 398
  • [7] Early non-response to certolizumab pegol in rheumatoid arthritis predicts treatment failure at one year. Data from a randomised phase III clinical trial
    Berenbaum, Francis
    Thao Pham
    Claudepierre, Pascal
    de Chalus, Thibault
    Joubert, Jean-Michel
    Saadoun, Carine
    Franca, Lionel Riou
    Fautrel, Bruno
    [J]. JOINT BONE SPINE, 2018, 85 (01) : 54 - 59
  • [8] Certolizumab pegol for the treatment of rheumatoid arthritis
    Horton, Sarah
    Walsh, Ceara
    Emery, Paul
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (02) : 235 - 249
  • [9] SYNOVIAL ECTOPIC LYMPHONEOGENESIS PREDICTS PRIMARY CLINICAL RESPONSE TO CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Di Cicco, Maria
    Kelly, Stephen
    Humby, Frances
    Ng, Nora
    Hands, Rebecca E.
    Rocher, Vidalba
    Nerviani, Alessandra
    Zou, Lu
    Bombardieri, Michele
    Pitzalis, Costantino
    [J]. RHEUMATOLOGY, 2014, 53 : 95 - 95
  • [10] Certolizumab pegol in active rheumatoid arthritis
    Aarat M. Patel
    Larry W. Moreland
    [J]. Current Rheumatology Reports, 2009, 11 (5) : 311 - 312